HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

LNSR

LENSAR, Inc.

Healthcare — Medical Devices

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

None 2 analysts
$6.57
$-0.02 (-0.30%)
Target: $8.50 (29.4%)

Price History

52-Week Range
Sign in to add LNSR to a watchlist or set price alerts.

Fundamentals

Market Cap$61.53M
P/E Ratio (TTM)-
Forward P/E-7.06
EPS (TTM)$-0.55
Dividend Yield-
Profit Margin50.94%
Revenue Growth-5.20%
ROE362.55%
Debt/Equity10.47
Recommendation None
Analyst Target$8.50
Analysts2
Next Earnings Aug 13, 2026 BMO
Indexes -

Technical Indicators

RSI (14)13.5
Beta0.87
SMA 20$5.69
SMA 40$5.76
52-Week High$13.20
52-Week Low$4.95
50-Day Avg$5.78
200-Day Avg$8.82
Avg Volume69.8K
Volume109.9K

Performance Analysis

BULLISH

LNSR shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 20% of its 52-week range.
+ RSI at 13.5 signals oversold conditions — a bounce may be ahead.
- Revenue declined 5.2% year-over-year.
+ Healthy profit margin of 50.9%.
~ Wall Street consensus is "none" from 2 analysts.
+ Average analyst target of $8.50 implies 29.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:16 UTC

Back to Screener Export Report